Vol. 23 - Num. 89
aServicio de Pediatría. Complejo Hospitalario de Navarra. Servicio Navarro de Salud . Pamplona. España.
bServicio de Pediatría. Complejo Hospitalario de Navarra. Servicio Navarro de Salud. Pamplona. Instituto de Investigación Sanitaria de Navarra (IdiSNA). Pamplona. España.
cInstituto de Investigación Sanitaria de Navarra (IdiSNA). Pamplona. Instituto de Salud Pública y Laboral de Navarra. Pamplona. CIBER Epidemiología y Salud Pública (CIBERESP). España.
dServicio de Pediatría. Complejo Hospitalario de Navarra. Servicio Navarro de Salud. Pamplona. España.
eSección de Enfermedades Infecciosas Pediátricas. Servicio de Pediatría. Complejo Hospitalario de Navarra. Servicio Navarro de Salud. Pamplona. Instituto de Investigación Sanitaria de Navarra (IdisNA). Pamplona. España.
Correspondence: M Urretavizcaya . E-mail: firstname.lastname@example.org
Reference of this article: Urretavizcaya Martínez M, Moreno Galarraga L, Castilla J, García Howard M, Belza Mendikute A, Herranz Aguirre M. Epidemiology of SARS-CoV-2 infection in Navarre (Spain). Rev Pediatr Aten Primaria. 2021;23:53-61.
Published in Internet: 29-03-2021 - Visits: 5467
Introduction: since the recent outbreak of coronavirus disease 2019 (COVID-19), extensive research has been performed, but information on the impact of SARS-CoV-2 infection in children is still limited. Incidence and clinical features in pediatric population remain unclear and studies are needed to further understand pediatric COVID-19.
Methods: in this multi-centre retrospective study, we describe the incidence and clinical characteristics of children with laboratory-confirmed COVID-19 in Navarre, Spain, during the first epidemic wave (February 28th - May 31st, 2020).
Results: pediatric COVID-19 cumulative incidence in Navarre during these 3 months was three per 1000 children. Of the 309 confirmed cases, 85.7% reported a positive household contact. We found that 32.1% of the patients were asymptomatic; symptoms were diverse and only 15.8% presented the “classic” fever and respiratory involvement. Of the total, 49% received telephone assistance, only 11.6% needed any complementary studies. Thirteen cases were admitted to the hospital (4.2%), from which only two were moderate cases (one respiratory that required oxygen and one epileptic) and one was a severe case presenting Multisystem Syndrome-Temporally associated with SARS-CoV-2 who needed intensive care. All patients had a favourable outcome without sequelae. Up to 45.2% did not require treatment, the rest received analgesics, inhaled medication or antibiotics in the case of coexisting bacterial infection; 2.3% received Hydroxychloroquine.
Conclusions: epidemiological reports are important for improving the current knowledge of COVID-19 in children, helping pediatricians to better recognize and adequately treat this disease.
Keywords● COVID-19 ● Pediatric coronavirus ● SARS-CoV-2
This article has no comments yet.